- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
AstraZeneca Pharma India Limited — Important, 03-10-2025: Product launch
03-10-2025 | 08:39 pm
03-10-2025 | 08:39 pm
AstraZeneca Pharma India has approval to launch Enhertu for an expanded use. It will now treat adult patients with unresectable or metastatic HER2-positive solid tumors who have received prior treatment and lack alternative options. This opens the market for its sale in India.
No comments yet. Be the first to comment!